Grufity logo
Grufity logo

Latest PERCEPTIVE ADVISORS LLC Stock Portfolio

$5.12Billion | No. of Holdings #91

Joseph Edelman Performance

2026 Q1+4.73%
YTD+4.73%
2025+57.06%

About Joseph Edelman and 13F Hedge Fund Stock Holdings

On 2026-05-29, the fund reported it's updated stock portfolio. In the 13F Holdings report, Joseph Edelman reported an equity portfolio of $5.1 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Joseph Edelman are PRAX, CELC, ASND. The fund has invested 12.8% of it's portfolio in PRAXIS PRECISION MEDICINES I and 7% of portfolio in CELCUITY INC. <br><br> The fund managers got completely rid off EXACT SCIENCES CORP (EXAS), ARCELLX INC (ACLX) and BOSTON SCIENTIFIC CORP (BSX) stocks. They significantly reduced their stock positions in NEUROCRINE BIOSCIENCES INC (NBIX), OMADA HEALTH INC and BELITE BIO INC (BLTE). Joseph Edelman opened new stock positions in IONIS PHARMACEUTICALS INC (IONS), DAY ONE BIOPHARMACEUTICALS I (DAWN) and DAMORA THERAPEUTICS INC (GLTO). The fund showed a lot of confidence in some stocks as they added substantially to SAB BIOTHERAPEUTICS INC (SABS), RELAY THERAPEUTICS INC (RLAY) and CORVUS PHARMACEUTICALS INC (CRVS).
Joseph Edelman Equity Portfolio Value
Last Reported on: 29 May, 2026
$5.12Billion
  as of May 29, 2026

Joseph Edelman Annual Return Estimates Vs S&P 500

Our best estimate is that PERCEPTIVE ADVISORS LLC made a return of 4.73% in the last quarter. In trailing 12 months, it's portfolio return was 80.03%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
ionis pharmaceuticals inc37,845,400
day one biopharmaceuticals i37,644,300
damora therapeutics inc31,675,700
revolution medicines inc25,148,800
dbv technologies s a20,146,100
sutro biopharma inc17,818,300
evommune inc10,307,600
phathom pharmaceuticals inc10,276,800
New stocks bought by PERCEPTIVE ADVISORS LLC

Additions

Ticker% Inc.
sab biotherapeutics inc700
relay therapeutics inc412
corvus pharmaceuticals inc231
tenax therapeutics inc229
biocryst pharmaceuticals inc135
anteris technologies global104
guardant health inc87.5
centessa pharmaceuticals plc80.25
Additions to existing portfolio by PERCEPTIVE ADVISORS LLC

Reductions

Ticker% Reduced
neurocrine biosciences inc-80.35
omada health inc-67.19
belite bio inc-63.31
viridian therapeutics inc-61.52
opus genetics inc-57.55
inhibikase therapeutics inc-57.3
crescent biopharma inc.-54.39
adma biologics inc-47.11
PERCEPTIVE ADVISORS LLC reduced stake in above stock

Sold off

Ticker$ Sold
astria therapeutics inc-84,894,100
amicus therapeutics inc-90,720,900
aldeyra therapeutics inc-21,681,600
gossamer bio inc-9,732,970
savara inc-14,472,000
arcellx inc-95,587,800
exact sciences corp-121,921,000
caris life sciences inc-30,654,800
PERCEPTIVE ADVISORS LLC got rid off the above stocks

Sector Distribution

PERCEPTIVE ADVISORS LLC has about 75.8% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare75.8
Others23.7

Market Cap. Distribution

PERCEPTIVE ADVISORS LLC has about 7.9% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
  • NANO-CAP
Category%
MID-CAP48.2
UNALLOCATED23.7
SMALL-CAP15.3
LARGE-CAP7.9
MICRO-CAP3.7
NANO-CAP1.1

Stocks belong to which Index?

About 42.5% of the stocks held by PERCEPTIVE ADVISORS LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others56.7
RUSSELL 200042.5
Top 5 Winners (%)%
NAUT
nautilus biotechnology inc
99.0 %
RVMD
revolution medicines inc
90.5 %
OCUP
opus genetics inc
90.0 %
TNGX
tango therapeutics inc
89.1 %
oruka therapeutics inc
60.1 %
Top 5 Winners ($)$
AGLE
spyre therapeutics inc
60.6 M
CNTA
centessa pharmaceuticals plc
60.1 M
PRAX
praxis precision medicines i
55.3 M
ROIV
roivant sciences ltd
48.8 M
CELC
celcuity inc
45.3 M
Top 5 Losers (%)%
beta bionics inc
-63.6 %
ADGI
invivyd inc
-46.4 %
ENSC
ensysce biosciences inc
-41.5 %
ADMA
adma biologics inc
-38.7 %
IRTC
irhythm holdings inc
-33.0 %
Top 5 Losers ($)$
RYTM
rhythm pharmaceuticals inc
-49.4 M
TVTX
travere therapeutics inc
-35.8 M
ADGI
invivyd inc
-24.9 M
VRDN
viridian therapeutics inc
-24.4 M
inhibrx biosciences inc
-17.0 M

Joseph Edelman Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Joseph Edelman

PERCEPTIVE ADVISORS LLC has 91 stocks in it's portfolio. About 51.4% of the portfolio is in top 10 stocks. RYTM proved to be the most loss making stock for the portfolio. AGLE was the most profitable stock for PERCEPTIVE ADVISORS LLC last quarter.

$5.06BTotal Value
130Positions
29 May, 2026Last Reported
Current holdings of Current Stock Holdings of Joseph Edelman, last reported on 29 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
Joseph Edelman's holding in Ascendis Pharma A/S over time
6.84%1,531,420
$350.28M
6.84%
increased 41.61 percentadded
BLTE
Belite Bio Inc

Belite Bio Inc

BLTE
Joseph Edelman's holding in Belite Bio Inc over time
0.47%151,979
$24.23M
0.47%
decreased 63.31 percentreduced